We should consider the role of CEA, IL-6, SAA1, MMP-9, LAC, and LDH in the perspective of having readily accessible and inexpensive diagnostic tools that can be employed effectively in the differential diagnosis of lung cancer stages IIB and IIA, and IIIA and IIB, and improve therapeutic decision making. The gene discussed is LCT; the disease is lung carcinoma.